DrugPatentWatch Database Preview
CETROTIDE Drug Profile
see a sample report or, see our see our flat-rate plans
Which patents cover Cetrotide, and what generic alternatives are available?
Cetrotide is a drug marketed by Emd Serono Inc and is included in one NDA. There is one patent protecting this drug.
The generic ingredient in CETROTIDE is cetrorelix. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the cetrorelix profile page.
Summary for CETROTIDE
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 36 |
| Clinical Trials: | 35 |
| Patent Applications: | 2,975 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CETROTIDE |
| DailyMed Link: | CETROTIDE at DailyMed |
Generic Entry Opportunity Date for CETROTIDE
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Synonyms for CETROTIDE
| (S)-1-(((R)-2-((S)-2-((S)-2-((R)-2-((R)-2-((R)-2-acetamido-3-(naphthalen-2-yl)propanamido)-3-(4-chlorophenyl)propanamido)-3-(pyridin-3-yl)propanamido)-3-hydroxypropanamido)-3-(4-hyd |
| 120287-85-6 |
| 130143-01-0 |
| 287C856 |
| ABP000574 |
| Ac-(D-Ala[3-(2-Naphthyl)])-[D-Phe(4-Cl)]-(D-Ala[3-(3-Pyridyl)])-Ser-Tyr-(D-Cit)-Leu-Arg-Pro-D-Ala-Oh |
| AC-28734 |
| Ac-D-Nal(2)-D-Phe(pCl)-D-Pal(3)-Ser-Tyr-D-Cit-Leu-Arg-Pro-D-Ala-NH2 |
| AKOS015994648 |
| AM000626 |
| BDBM50369965 |
| C-35500 |
| C70H92ClN17O14 |
| Cetrelix Acetate |
| Cetrorelix |
| Cetrorelix (INN) |
| Cetrorelix [INN:BAN] |
| Cetrorelix acetate |
| Cetrorelix Acetate(Cetrotide)/ |
| Cetrorelix(Cetrorelix acetate) |
| Cetrorelixum |
| Cetrorelixum [INN-Latin] |
| Cetrotide (TN) |
| CHEBI:59224 |
| CHEMBL1200490 |
| D07665 |
| D09OLZ |
| DB00050 |
| DTXSID7040996 |
| FT-0647968 |
| FT-0656251 |
| GTPL1190 |
| HS-2008 |
| HSDB 7696 |
| KS-00002WUP |
| MolPort-009-194-176 |
| MolPort-042-652-596 |
| N-acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-L-tyrosyl-N5-carbomoyl-D-ornithyl-L-leucyl-L-prolyl-D-alaninamide |
| N-Acetyl-3-(2-naphthyl)-D-alanyl-p-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-L-tyrosyl-N(sup 5)-carbamoyl-D-ornithyl-L-leucyl-L-arginyl-L-prolyl-D-alaninamide |
| N-acetyl-3-(naphthalen-2-yl)-D-alanyl-4-chloro-D-phenylalanyl-3-(pyridin-3-yl)-D-alanyl-L-seryl-L-tyrosyl-N(5)-carbamoyl-D-ornithyl-L-leucyl-L-arginyl-L-prolyl-D-alaninamide |
| OON1HFZ4BA |
| roxyphenyl)propanamido)-5-ureidopentanoyl)-L-leucyl-L-arginyl)-N-((R)-1-amino-1-oxopropan-2-yl)pyrrolidine-2-carboxamide |
| SB 75 |
| SB-075 |
| SC-50568 |
| SC-82639 |
| SCHEMBL19712202 |
| SCHEMBL61331 |
| UNII-OON1HFZ4BA |
| V0412 |
| Y-100040 |
US Patents and Regulatory Information for CETROTIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emd Serono Inc | CETROTIDE | cetrorelix | INJECTABLE;INJECTION | 021197-001 | Aug 11, 2000 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Emd Serono Inc | CETROTIDE | cetrorelix | INJECTABLE;INJECTION | 021197-002 | Aug 11, 2000 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
Expired US Patents for CETROTIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Emd Serono Inc | CETROTIDE | cetrorelix | INJECTABLE;INJECTION | 021197-001 | Aug 11, 2000 | ➤ Sign Up | ➤ Sign Up |
| Emd Serono Inc | CETROTIDE | cetrorelix | INJECTABLE;INJECTION | 021197-002 | Aug 11, 2000 | ➤ Sign Up | ➤ Sign Up |
| Emd Serono Inc | CETROTIDE | cetrorelix | INJECTABLE;INJECTION | 021197-001 | Aug 11, 2000 | ➤ Sign Up | ➤ Sign Up |
| Emd Serono Inc | CETROTIDE | cetrorelix | INJECTABLE;INJECTION | 021197-001 | Aug 11, 2000 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
see a sample report or, see our see our flat-rate plans
International Patents for CETROTIDE
Supplementary Protection Certificates for CETROTIDE
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 9C0031 | Belgium | ➤ Sign Up | PRODUCT NAME: ACETATE DE CETRORELIX; REGISTRATION NO/DATE: EU/1/99/100/001 19990413 |
| 90029 | Netherlands | ➤ Sign Up | PRODUCT NAME: CETRORELIX, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAAR DBAAR ZUUR ADDITIEZOUT, IN HET BIJZONDER CETRORELIX ACETAAT; REGISTRATION NO/DATE: EU/1/99/100/001-003 19990413 |
| /1999 | Austria | ➤ Sign Up | PRODUCT NAME: CETRORELIX UND PHARMAZEUTISCH ANNEHMBARE SAEUREADDITIONSSALZE DAVON, INSBESONDERE CETRORELIXACETAT; REGISTRATION NO/DATE: EU/1/99/100/001- EU/1/99/100/003 19990413 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
